HBsAg水平可用于排除HBeAg阳性慢性乙型肝炎患者的肝硬化:SONIC-B研究结果
基于SONIC-B数据库(8项全球随机试验和2个大型肝病中心)的2779例患者数据,其中1866例HBeAg阳性、322例肝硬化。基因型特异性HBsAg界值阴性预测值>97%,误分类率≤7.1%,可作为FIB-4的辅助工具排除肝硬化。
要点
- HBeAg阳性患者中HBsAg水平越低,显著纤维化和肝硬化风险越高
- 基因型特异性HBsAg界值阴性预测值>97%,可用于排除肝硬化
- HBsAg界值可作为FIB-4的辅助手段,减少进一步检查需求
核心结论
- 基因型特异性HBsAg界值可用于排除基因B、C、D型HBeAg阳性患者的肝硬化,并可作为FIB-4的辅助工具减少进一步检查。
研究设计与样本
- 分析SONIC-B数据库,该数据库包含8项全球随机试验和2个大型肝病中心的数据,共2779例患者。
主要发现
- 在HBeAg阴性患者中未观察到HBsAg水平与纤维化或肝硬化的关系。
- 在HBeAg阳性患者中,基因型特异性HBsAg界值的阴性预测值>97%,误分类率≤7.1%。
- 在FIB-4无法排除肝硬化的患者中,HBsAg界值的诊断性能相当。
关键数值与推荐
- 基因型特异性HBsAg界值的阴性预测值>97%,误分类率≤7.1%。
临床怎么用
- 对于HBeAg阳性、基因B、C、D型的慢性乙型肝炎患者,可考虑使用基因型特异性HBsAg界值辅助排除肝硬化。
- HBsAg界值可与FIB-4联合使用,以减少不必要的进一步检查。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Serum hepatitis B surface antigen (HBsAg) levels correlate with the duration of chronic hepatitis B virus (HBV) infection and may predict the extent of hepatic fibrosis. METHODS: We analyzed data from the SONIC-B database, which contains data from 8 global randomized trials and 2 large hepatology centers. Relationship between HBsAg levels and presence of significant fibrosis (Ishak 3-4) or cirrhosis (Ishak 5-6) were explored, and clinically relevant cutoffs were identified to rule out cirrhosis. RESULTS: The dataset included 2779 patients: 1866 hepatitis B e antigen (HBeAg)-positive; 322 with cirrhosis. Among HBeAg-positive patients, lower HBsAg levels were associated with higher rates of significant fibrosis (odds ratio [OR], 0.419; P < .001) and cirrhosis (OR, 0.435; P < .001). No relationship was observed among HBeAg-negative patients. Among HBeAg-positive patients, genotype-specific HBsAg cutoffs had excellent negative predictive values (>97%) and low misclassification rates (≤7.1%) and may therefore have utility in ruling out cirrhosis. Diagnostic performance of the HBsAg cutoffs was comparable among patients in whom cirrhosis could not be ruled out with fibrosis 4 (FIB-4). CONCLUSIONS: Hepatitis B virus genotype-specific HBsAg cutoffs may have utility in ruling out presence of cirrhosis in HBeAg-positive patients with genotypes B, C, and D and can be an adjunct to FIB-4 to reduce the need for further testing.
引用
- Sonneveld MJ, Hansen BE, Brouwer WP, et al. Hepatitis B Surface Antigen Levels Can Be Used to Rule Out Cirrhosis in Hepatitis B e Antigen-Positive Chronic Hepatitis B: Results From the SONIC-B Study. J Infect Dis. 2022. PMID: 32318704. doi:10.1093/infdis/jiaa192
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。